Most ICI-DM patients require lifelong insulin therapy post-acute phase, the treatment goal is to prevent DKA and avoid severe hypoglycemia, which can be achieved through relatively low doses of basal insulin (0.05–0.1 U/kg/day). Here, INS is linked to Hypoglycemia.